nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—CYP1A2—Imiquimod—skin cancer	0.134	0.166	CbGbCtD
Toremifene—CYP1A1—Dacarbazine—skin cancer	0.126	0.156	CbGbCtD
Toremifene—ABCB1—Vismodegib—skin cancer	0.081	0.1	CbGbCtD
Toremifene—CYP1A2—Vemurafenib—skin cancer	0.0732	0.0907	CbGbCtD
Toremifene—CYP3A4—Imiquimod—skin cancer	0.07	0.0868	CbGbCtD
Toremifene—CYP3A4—Temozolomide—skin cancer	0.07	0.0868	CbGbCtD
Toremifene—CYP1A2—Dacarbazine—skin cancer	0.0561	0.0695	CbGbCtD
Toremifene—CYP3A4—Vismodegib—skin cancer	0.0485	0.0601	CbGbCtD
Toremifene—ABCB1—Dactinomycin—skin cancer	0.0426	0.0527	CbGbCtD
Toremifene—CYP3A4—Vemurafenib—skin cancer	0.0384	0.0475	CbGbCtD
Toremifene—CYP1A2—Fluorouracil—skin cancer	0.0329	0.0408	CbGbCtD
Toremifene—ABCB1—Docetaxel—skin cancer	0.022	0.0272	CbGbCtD
Toremifene—CYP3A4—Docetaxel—skin cancer	0.0132	0.0163	CbGbCtD
Toremifene—Malnutrition—Vismodegib—skin cancer	0.00159	0.00826	CcSEcCtD
Toremifene—Vaginal haemorrhage—Temozolomide—skin cancer	0.00155	0.00806	CcSEcCtD
Toremifene—Back pain—Vismodegib—skin cancer	0.00154	0.00799	CcSEcCtD
Toremifene—Arthritis—Imiquimod—skin cancer	0.00143	0.00744	CcSEcCtD
Toremifene—Cardiac failure—Imiquimod—skin cancer	0.00143	0.00741	CcSEcCtD
Toremifene—Lethargy—Imiquimod—skin cancer	0.00142	0.00737	CcSEcCtD
Toremifene—Rigors—Temozolomide—skin cancer	0.00141	0.00731	CcSEcCtD
Toremifene—Foetor hepaticus—Docetaxel—skin cancer	0.00135	0.00699	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00135	0.00698	CcSEcCtD
Toremifene—Nervous system disorder—Vismodegib—skin cancer	0.00127	0.00661	CcSEcCtD
Toremifene—Skin disorder—Vismodegib—skin cancer	0.00126	0.00655	CcSEcCtD
Toremifene—Breast disorder—Imiquimod—skin cancer	0.00126	0.00653	CcSEcCtD
Toremifene—Polyp—Docetaxel—skin cancer	0.00126	0.00652	CcSEcCtD
Toremifene—Deep vein thrombosis—Docetaxel—skin cancer	0.00126	0.00652	CcSEcCtD
Toremifene—Neuropathy peripheral—Vemurafenib—skin cancer	0.00123	0.0064	CcSEcCtD
Toremifene—Embolism—Docetaxel—skin cancer	0.00119	0.00618	CcSEcCtD
Toremifene—Coordination abnormal—Temozolomide—skin cancer	0.00117	0.00608	CcSEcCtD
Toremifene—Pulmonary embolism—Temozolomide—skin cancer	0.00115	0.00597	CcSEcCtD
Toremifene—Cyst—Docetaxel—skin cancer	0.00114	0.00594	CcSEcCtD
Toremifene—Decreased appetite—Vismodegib—skin cancer	0.00113	0.00586	CcSEcCtD
Toremifene—Liver disorder—Docetaxel—skin cancer	0.00112	0.00582	CcSEcCtD
Toremifene—Gastrointestinal disorder—Vismodegib—skin cancer	0.00112	0.00582	CcSEcCtD
Toremifene—Fatigue—Vismodegib—skin cancer	0.00112	0.00581	CcSEcCtD
Toremifene—Pain—Vismodegib—skin cancer	0.00111	0.00577	CcSEcCtD
Toremifene—Constipation—Vismodegib—skin cancer	0.00111	0.00577	CcSEcCtD
Toremifene—Dry eye—Temozolomide—skin cancer	0.00106	0.00551	CcSEcCtD
Toremifene—Acute coronary syndrome—Imiquimod—skin cancer	0.00106	0.00549	CcSEcCtD
Toremifene—Eye disorder—Vemurafenib—skin cancer	0.00106	0.00548	CcSEcCtD
Toremifene—Neuropathy peripheral—Imiquimod—skin cancer	0.00105	0.00546	CcSEcCtD
Toremifene—Myocardial infarction—Imiquimod—skin cancer	0.00105	0.00546	CcSEcCtD
Toremifene—Angiopathy—Vemurafenib—skin cancer	0.00102	0.00532	CcSEcCtD
Toremifene—Mediastinal disorder—Vemurafenib—skin cancer	0.00102	0.00528	CcSEcCtD
Toremifene—Arthritis—Bleomycin—skin cancer	0.00102	0.00528	CcSEcCtD
Toremifene—Hepatobiliary disease—Imiquimod—skin cancer	0.00101	0.00527	CcSEcCtD
Toremifene—Chills—Vemurafenib—skin cancer	0.00101	0.00526	CcSEcCtD
Toremifene—Abnormal vision—Temozolomide—skin cancer	0.001	0.0052	CcSEcCtD
Toremifene—Alopecia—Vemurafenib—skin cancer	0.000998	0.00518	CcSEcCtD
Toremifene—Malnutrition—Vemurafenib—skin cancer	0.000983	0.0051	CcSEcCtD
Toremifene—Thrombophlebitis—Temozolomide—skin cancer	0.000964	0.005	CcSEcCtD
Toremifene—Back pain—Vemurafenib—skin cancer	0.000951	0.00494	CcSEcCtD
Toremifene—Lethargy—Dactinomycin—skin cancer	0.000942	0.00489	CcSEcCtD
Toremifene—Rigors—Docetaxel—skin cancer	0.000936	0.00486	CcSEcCtD
Toremifene—Asthenia—Vismodegib—skin cancer	0.000932	0.00484	CcSEcCtD
Toremifene—Visual impairment—Imiquimod—skin cancer	0.000928	0.00482	CcSEcCtD
Toremifene—Pruritus—Vismodegib—skin cancer	0.000919	0.00477	CcSEcCtD
Toremifene—Eye disorder—Imiquimod—skin cancer	0.0009	0.00467	CcSEcCtD
Toremifene—Hot flush—Temozolomide—skin cancer	0.000892	0.00463	CcSEcCtD
Toremifene—Thrombophlebitis—Fluorouracil—skin cancer	0.000888	0.00461	CcSEcCtD
Toremifene—Menopausal symptoms—Temozolomide—skin cancer	0.000884	0.00459	CcSEcCtD
Toremifene—Angiopathy—Imiquimod—skin cancer	0.000874	0.00454	CcSEcCtD
Toremifene—Mediastinal disorder—Imiquimod—skin cancer	0.000868	0.00451	CcSEcCtD
Toremifene—Chills—Imiquimod—skin cancer	0.000864	0.00449	CcSEcCtD
Toremifene—Arrhythmia—Imiquimod—skin cancer	0.000861	0.00447	CcSEcCtD
Toremifene—Liver function test abnormal—Dactinomycin—skin cancer	0.000852	0.00442	CcSEcCtD
Toremifene—Alopecia—Imiquimod—skin cancer	0.000851	0.00442	CcSEcCtD
Toremifene—Mental disorder—Imiquimod—skin cancer	0.000844	0.00438	CcSEcCtD
Toremifene—Malnutrition—Imiquimod—skin cancer	0.000839	0.00435	CcSEcCtD
Toremifene—Diplopia—Temozolomide—skin cancer	0.000835	0.00433	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.000831	0.00431	CcSEcCtD
Toremifene—Vomiting—Vismodegib—skin cancer	0.000826	0.00429	CcSEcCtD
Toremifene—Affect lability—Temozolomide—skin cancer	0.000821	0.00426	CcSEcCtD
Toremifene—Rash—Vismodegib—skin cancer	0.000819	0.00425	CcSEcCtD
Toremifene—Dermatitis—Vismodegib—skin cancer	0.000818	0.00425	CcSEcCtD
Toremifene—Back pain—Imiquimod—skin cancer	0.000811	0.00421	CcSEcCtD
Toremifene—Mood swings—Temozolomide—skin cancer	0.000791	0.0041	CcSEcCtD
Toremifene—Cardiac failure—Fluorouracil—skin cancer	0.000788	0.00409	CcSEcCtD
Toremifene—Nervous system disorder—Vemurafenib—skin cancer	0.000787	0.00408	CcSEcCtD
Toremifene—Ataxia—Temozolomide—skin cancer	0.000785	0.00407	CcSEcCtD
Toremifene—Lethargy—Fluorouracil—skin cancer	0.000785	0.00407	CcSEcCtD
Toremifene—Skin disorder—Vemurafenib—skin cancer	0.00078	0.00405	CcSEcCtD
Toremifene—Nausea—Vismodegib—skin cancer	0.000772	0.004	CcSEcCtD
Toremifene—Pulmonary embolism—Docetaxel—skin cancer	0.000765	0.00397	CcSEcCtD
Toremifene—Hepatocellular injury—Docetaxel—skin cancer	0.000765	0.00397	CcSEcCtD
Toremifene—Breast disorder—Temozolomide—skin cancer	0.000754	0.00391	CcSEcCtD
Toremifene—Acute coronary syndrome—Bleomycin—skin cancer	0.000752	0.0039	CcSEcCtD
Toremifene—Myocardial infarction—Bleomycin—skin cancer	0.000747	0.00388	CcSEcCtD
Toremifene—Ataxia—Fluorouracil—skin cancer	0.000723	0.00375	CcSEcCtD
Toremifene—Chest pain—Imiquimod—skin cancer	0.000714	0.00371	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000709	0.00368	CcSEcCtD
Toremifene—Decreased appetite—Vemurafenib—skin cancer	0.000698	0.00362	CcSEcCtD
Toremifene—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000693	0.0036	CcSEcCtD
Toremifene—Fatigue—Vemurafenib—skin cancer	0.000692	0.00359	CcSEcCtD
Toremifene—Constipation—Vemurafenib—skin cancer	0.000686	0.00356	CcSEcCtD
Toremifene—Oedema—Imiquimod—skin cancer	0.000684	0.00355	CcSEcCtD
Toremifene—Nervous system disorder—Imiquimod—skin cancer	0.000671	0.00348	CcSEcCtD
Toremifene—Skin disorder—Imiquimod—skin cancer	0.000665	0.00345	CcSEcCtD
Toremifene—Hyperhidrosis—Imiquimod—skin cancer	0.000662	0.00343	CcSEcCtD
Toremifene—Weight increased—Temozolomide—skin cancer	0.000656	0.00341	CcSEcCtD
Toremifene—Anorexia—Imiquimod—skin cancer	0.000652	0.00339	CcSEcCtD
Toremifene—Angina pectoris—Fluorouracil—skin cancer	0.000647	0.00336	CcSEcCtD
Toremifene—Thrombophlebitis—Docetaxel—skin cancer	0.000641	0.00333	CcSEcCtD
Toremifene—Neuropathy peripheral—Temozolomide—skin cancer	0.00063	0.00327	CcSEcCtD
Toremifene—Insomnia—Imiquimod—skin cancer	0.000619	0.00321	CcSEcCtD
Toremifene—Chills—Bleomycin—skin cancer	0.000614	0.00319	CcSEcCtD
Toremifene—Dyspnoea—Imiquimod—skin cancer	0.00061	0.00317	CcSEcCtD
Toremifene—Hepatobiliary disease—Temozolomide—skin cancer	0.000608	0.00316	CcSEcCtD
Toremifene—Alopecia—Bleomycin—skin cancer	0.000605	0.00314	CcSEcCtD
Toremifene—Decreased appetite—Imiquimod—skin cancer	0.000595	0.00309	CcSEcCtD
Toremifene—Hot flush—Docetaxel—skin cancer	0.000593	0.00308	CcSEcCtD
Toremifene—Gastrointestinal disorder—Imiquimod—skin cancer	0.000591	0.00307	CcSEcCtD
Toremifene—Fatigue—Imiquimod—skin cancer	0.00059	0.00306	CcSEcCtD
Toremifene—Menopausal symptoms—Docetaxel—skin cancer	0.000588	0.00305	CcSEcCtD
Toremifene—Pain—Imiquimod—skin cancer	0.000585	0.00304	CcSEcCtD
Toremifene—Acute coronary syndrome—Fluorouracil—skin cancer	0.000584	0.00303	CcSEcCtD
Toremifene—Neuropathy peripheral—Fluorouracil—skin cancer	0.000581	0.00301	CcSEcCtD
Toremifene—Myocardial infarction—Fluorouracil—skin cancer	0.000581	0.00301	CcSEcCtD
Toremifene—Asthenia—Vemurafenib—skin cancer	0.000576	0.00299	CcSEcCtD
Toremifene—Chills—Dactinomycin—skin cancer	0.000573	0.00297	CcSEcCtD
Toremifene—Cardiac failure—Docetaxel—skin cancer	0.000569	0.00295	CcSEcCtD
Toremifene—Pruritus—Vemurafenib—skin cancer	0.000568	0.00295	CcSEcCtD
Toremifene—Lethargy—Docetaxel—skin cancer	0.000566	0.00294	CcSEcCtD
Toremifene—Alopecia—Dactinomycin—skin cancer	0.000564	0.00293	CcSEcCtD
Toremifene—Visual impairment—Temozolomide—skin cancer	0.000556	0.00289	CcSEcCtD
Toremifene—Eye disorder—Temozolomide—skin cancer	0.00054	0.0028	CcSEcCtD
Toremifene—Leukopenia—Bleomycin—skin cancer	0.000533	0.00277	CcSEcCtD
Toremifene—Dizziness—Vemurafenib—skin cancer	0.000531	0.00275	CcSEcCtD
Toremifene—Angiopathy—Temozolomide—skin cancer	0.000524	0.00272	CcSEcCtD
Toremifene—Ataxia—Docetaxel—skin cancer	0.000522	0.00271	CcSEcCtD
Toremifene—Mediastinal disorder—Temozolomide—skin cancer	0.00052	0.0027	CcSEcCtD
Toremifene—Chills—Temozolomide—skin cancer	0.000518	0.00269	CcSEcCtD
Toremifene—Liver function test abnormal—Docetaxel—skin cancer	0.000512	0.00266	CcSEcCtD
Toremifene—Vomiting—Vemurafenib—skin cancer	0.00051	0.00265	CcSEcCtD
Toremifene—Alopecia—Temozolomide—skin cancer	0.00051	0.00265	CcSEcCtD
Toremifene—Chest pain—Bleomycin—skin cancer	0.000507	0.00263	CcSEcCtD
Toremifene—Rash—Vemurafenib—skin cancer	0.000506	0.00263	CcSEcCtD
Toremifene—Mental disorder—Temozolomide—skin cancer	0.000506	0.00262	CcSEcCtD
Toremifene—Dermatitis—Vemurafenib—skin cancer	0.000506	0.00262	CcSEcCtD
Toremifene—Headache—Vemurafenib—skin cancer	0.000503	0.00261	CcSEcCtD
Toremifene—Malnutrition—Temozolomide—skin cancer	0.000503	0.00261	CcSEcCtD
Toremifene—Breast disorder—Docetaxel—skin cancer	0.000502	0.0026	CcSEcCtD
Toremifene—Leukopenia—Dactinomycin—skin cancer	0.000497	0.00258	CcSEcCtD
Toremifene—Asthenia—Imiquimod—skin cancer	0.000491	0.00255	CcSEcCtD
Toremifene—Oedema—Bleomycin—skin cancer	0.000486	0.00252	CcSEcCtD
Toremifene—Back pain—Temozolomide—skin cancer	0.000486	0.00252	CcSEcCtD
Toremifene—Pruritus—Imiquimod—skin cancer	0.000484	0.00251	CcSEcCtD
Toremifene—Nausea—Vemurafenib—skin cancer	0.000477	0.00247	CcSEcCtD
Toremifene—Thrombocytopenia—Bleomycin—skin cancer	0.000476	0.00247	CcSEcCtD
Toremifene—Arrhythmia—Fluorouracil—skin cancer	0.000475	0.00247	CcSEcCtD
Toremifene—Vision blurred—Temozolomide—skin cancer	0.000474	0.00246	CcSEcCtD
Toremifene—Tremor—Temozolomide—skin cancer	0.000471	0.00244	CcSEcCtD
Toremifene—Alopecia—Fluorouracil—skin cancer	0.00047	0.00244	CcSEcCtD
Toremifene—Angina pectoris—Docetaxel—skin cancer	0.000467	0.00242	CcSEcCtD
Toremifene—Anorexia—Bleomycin—skin cancer	0.000463	0.00241	CcSEcCtD
Toremifene—Oedema—Dactinomycin—skin cancer	0.000453	0.00235	CcSEcCtD
Toremifene—Dizziness—Imiquimod—skin cancer	0.000453	0.00235	CcSEcCtD
Toremifene—Vertigo—Temozolomide—skin cancer	0.000452	0.00234	CcSEcCtD
Toremifene—Leukopenia—Temozolomide—skin cancer	0.00045	0.00233	CcSEcCtD
Toremifene—Thrombocytopenia—Dactinomycin—skin cancer	0.000444	0.0023	CcSEcCtD
Toremifene—Weight increased—Docetaxel—skin cancer	0.000437	0.00227	CcSEcCtD
Toremifene—Vision blurred—Fluorouracil—skin cancer	0.000436	0.00226	CcSEcCtD
Toremifene—Vomiting—Imiquimod—skin cancer	0.000435	0.00226	CcSEcCtD
Toremifene—Dyspnoea—Bleomycin—skin cancer	0.000434	0.00225	CcSEcCtD
Toremifene—Anorexia—Dactinomycin—skin cancer	0.000432	0.00224	CcSEcCtD
Toremifene—Rash—Imiquimod—skin cancer	0.000432	0.00224	CcSEcCtD
Toremifene—Dermatitis—Imiquimod—skin cancer	0.000431	0.00224	CcSEcCtD
Toremifene—Headache—Imiquimod—skin cancer	0.000429	0.00223	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000425	0.00221	CcSEcCtD
Toremifene—Decreased appetite—Bleomycin—skin cancer	0.000423	0.00219	CcSEcCtD
Toremifene—Acute coronary syndrome—Docetaxel—skin cancer	0.000422	0.00219	CcSEcCtD
Toremifene—Myocardial infarction—Docetaxel—skin cancer	0.000419	0.00218	CcSEcCtD
Toremifene—Neuropathy peripheral—Docetaxel—skin cancer	0.000419	0.00218	CcSEcCtD
Toremifene—Jaundice—Docetaxel—skin cancer	0.000417	0.00216	CcSEcCtD
Toremifene—Pain—Bleomycin—skin cancer	0.000416	0.00216	CcSEcCtD
Toremifene—Leukopenia—Fluorouracil—skin cancer	0.000414	0.00215	CcSEcCtD
Toremifene—Oedema—Temozolomide—skin cancer	0.00041	0.00213	CcSEcCtD
Toremifene—Nausea—Imiquimod—skin cancer	0.000407	0.00211	CcSEcCtD
Toremifene—Hepatobiliary disease—Docetaxel—skin cancer	0.000404	0.0021	CcSEcCtD
Toremifene—Nervous system disorder—Temozolomide—skin cancer	0.000402	0.00209	CcSEcCtD
Toremifene—Thrombocytopenia—Temozolomide—skin cancer	0.000402	0.00208	CcSEcCtD
Toremifene—Skin disorder—Temozolomide—skin cancer	0.000398	0.00207	CcSEcCtD
Toremifene—Hyperhidrosis—Temozolomide—skin cancer	0.000397	0.00206	CcSEcCtD
Toremifene—Chest pain—Fluorouracil—skin cancer	0.000394	0.00205	CcSEcCtD
Toremifene—Decreased appetite—Dactinomycin—skin cancer	0.000394	0.00205	CcSEcCtD
Toremifene—Fatigue—Dactinomycin—skin cancer	0.000391	0.00203	CcSEcCtD
Toremifene—Anorexia—Temozolomide—skin cancer	0.000391	0.00203	CcSEcCtD
Toremifene—Pain—Dactinomycin—skin cancer	0.000388	0.00201	CcSEcCtD
Toremifene—Oedema—Fluorouracil—skin cancer	0.000378	0.00196	CcSEcCtD
Toremifene—Insomnia—Temozolomide—skin cancer	0.000371	0.00193	CcSEcCtD
Toremifene—Nervous system disorder—Fluorouracil—skin cancer	0.000371	0.00192	CcSEcCtD
Toremifene—Thrombocytopenia—Fluorouracil—skin cancer	0.00037	0.00192	CcSEcCtD
Toremifene—Visual impairment—Docetaxel—skin cancer	0.00037	0.00192	CcSEcCtD
Toremifene—Dyspnoea—Temozolomide—skin cancer	0.000366	0.0019	CcSEcCtD
Toremifene—Anorexia—Fluorouracil—skin cancer	0.00036	0.00187	CcSEcCtD
Toremifene—Eye disorder—Docetaxel—skin cancer	0.000359	0.00186	CcSEcCtD
Toremifene—Decreased appetite—Temozolomide—skin cancer	0.000357	0.00185	CcSEcCtD
Toremifene—Gastrointestinal disorder—Temozolomide—skin cancer	0.000354	0.00184	CcSEcCtD
Toremifene—Fatigue—Temozolomide—skin cancer	0.000354	0.00184	CcSEcCtD
Toremifene—Pain—Temozolomide—skin cancer	0.000351	0.00182	CcSEcCtD
Toremifene—Constipation—Temozolomide—skin cancer	0.000351	0.00182	CcSEcCtD
Toremifene—Asthenia—Bleomycin—skin cancer	0.000349	0.00181	CcSEcCtD
Toremifene—Angiopathy—Docetaxel—skin cancer	0.000348	0.00181	CcSEcCtD
Toremifene—Mediastinal disorder—Docetaxel—skin cancer	0.000346	0.0018	CcSEcCtD
Toremifene—Chills—Docetaxel—skin cancer	0.000344	0.00179	CcSEcCtD
Toremifene—Pruritus—Bleomycin—skin cancer	0.000344	0.00179	CcSEcCtD
Toremifene—Arrhythmia—Docetaxel—skin cancer	0.000343	0.00178	CcSEcCtD
Toremifene—Insomnia—Fluorouracil—skin cancer	0.000342	0.00177	CcSEcCtD
Toremifene—Alopecia—Docetaxel—skin cancer	0.000339	0.00176	CcSEcCtD
Toremifene—Dyspnoea—Fluorouracil—skin cancer	0.000337	0.00175	CcSEcCtD
Toremifene—Mental disorder—Docetaxel—skin cancer	0.000336	0.00175	CcSEcCtD
Toremifene—Malnutrition—Docetaxel—skin cancer	0.000334	0.00173	CcSEcCtD
Toremifene—Decreased appetite—Fluorouracil—skin cancer	0.000329	0.0017	CcSEcCtD
Toremifene—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000326	0.00169	CcSEcCtD
Toremifene—Asthenia—Dactinomycin—skin cancer	0.000325	0.00169	CcSEcCtD
Toremifene—Back pain—Docetaxel—skin cancer	0.000323	0.00168	CcSEcCtD
Toremifene—Pain—Fluorouracil—skin cancer	0.000323	0.00168	CcSEcCtD
Toremifene—Vomiting—Bleomycin—skin cancer	0.000309	0.0016	CcSEcCtD
Toremifene—Rash—Bleomycin—skin cancer	0.000307	0.00159	CcSEcCtD
Toremifene—Dermatitis—Bleomycin—skin cancer	0.000306	0.00159	CcSEcCtD
Toremifene—Leukopenia—Docetaxel—skin cancer	0.000299	0.00155	CcSEcCtD
Toremifene—Asthenia—Temozolomide—skin cancer	0.000294	0.00153	CcSEcCtD
Toremifene—Pruritus—Temozolomide—skin cancer	0.00029	0.00151	CcSEcCtD
Toremifene—Nausea—Bleomycin—skin cancer	0.000289	0.0015	CcSEcCtD
Toremifene—Vomiting—Dactinomycin—skin cancer	0.000288	0.0015	CcSEcCtD
Toremifene—Rash—Dactinomycin—skin cancer	0.000286	0.00148	CcSEcCtD
Toremifene—Chest pain—Docetaxel—skin cancer	0.000285	0.00148	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000283	0.00147	CcSEcCtD
Toremifene—Oedema—Docetaxel—skin cancer	0.000273	0.00142	CcSEcCtD
Toremifene—Dizziness—Temozolomide—skin cancer	0.000271	0.00141	CcSEcCtD
Toremifene—Nausea—Dactinomycin—skin cancer	0.000269	0.0014	CcSEcCtD
Toremifene—Nervous system disorder—Docetaxel—skin cancer	0.000267	0.00139	CcSEcCtD
Toremifene—Pruritus—Fluorouracil—skin cancer	0.000267	0.00139	CcSEcCtD
Toremifene—Thrombocytopenia—Docetaxel—skin cancer	0.000267	0.00139	CcSEcCtD
Toremifene—Skin disorder—Docetaxel—skin cancer	0.000265	0.00137	CcSEcCtD
Toremifene—Vomiting—Temozolomide—skin cancer	0.000261	0.00135	CcSEcCtD
Toremifene—Anorexia—Docetaxel—skin cancer	0.00026	0.00135	CcSEcCtD
Toremifene—Rash—Temozolomide—skin cancer	0.000259	0.00134	CcSEcCtD
Toremifene—Dermatitis—Temozolomide—skin cancer	0.000258	0.00134	CcSEcCtD
Toremifene—Headache—Temozolomide—skin cancer	0.000257	0.00133	CcSEcCtD
Toremifene—Dizziness—Fluorouracil—skin cancer	0.00025	0.0013	CcSEcCtD
Toremifene—Insomnia—Docetaxel—skin cancer	0.000247	0.00128	CcSEcCtD
Toremifene—Nausea—Temozolomide—skin cancer	0.000244	0.00126	CcSEcCtD
Toremifene—Dyspnoea—Docetaxel—skin cancer	0.000243	0.00126	CcSEcCtD
Toremifene—Vomiting—Fluorouracil—skin cancer	0.00024	0.00125	CcSEcCtD
Toremifene—Rash—Fluorouracil—skin cancer	0.000238	0.00124	CcSEcCtD
Toremifene—Dermatitis—Fluorouracil—skin cancer	0.000238	0.00124	CcSEcCtD
Toremifene—Decreased appetite—Docetaxel—skin cancer	0.000237	0.00123	CcSEcCtD
Toremifene—Headache—Fluorouracil—skin cancer	0.000237	0.00123	CcSEcCtD
Toremifene—Gastrointestinal disorder—Docetaxel—skin cancer	0.000235	0.00122	CcSEcCtD
Toremifene—Fatigue—Docetaxel—skin cancer	0.000235	0.00122	CcSEcCtD
Toremifene—Constipation—Docetaxel—skin cancer	0.000233	0.00121	CcSEcCtD
Toremifene—Pain—Docetaxel—skin cancer	0.000233	0.00121	CcSEcCtD
Toremifene—Nausea—Fluorouracil—skin cancer	0.000224	0.00116	CcSEcCtD
Toremifene—Asthenia—Docetaxel—skin cancer	0.000196	0.00102	CcSEcCtD
Toremifene—Pruritus—Docetaxel—skin cancer	0.000193	0.001	CcSEcCtD
Toremifene—Dizziness—Docetaxel—skin cancer	0.00018	0.000936	CcSEcCtD
Toremifene—Vomiting—Docetaxel—skin cancer	0.000173	0.0009	CcSEcCtD
Toremifene—Rash—Docetaxel—skin cancer	0.000172	0.000893	CcSEcCtD
Toremifene—Dermatitis—Docetaxel—skin cancer	0.000172	0.000892	CcSEcCtD
Toremifene—Headache—Docetaxel—skin cancer	0.000171	0.000887	CcSEcCtD
Toremifene—Nausea—Docetaxel—skin cancer	0.000162	0.000841	CcSEcCtD
